Clinical Trials List
Protocol NumberOTX-2002-101
Completed
2022-10-31 - 2026-12-31
Phase I
Recruiting2
-
Trial Applicant
CMIC Asia-Pacific
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- Chiun Hsu 未分科
- Chia-Chi Lin Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Jih-Hsiang Lee
- Ying-Chun Shen Division of Hematology & Oncology
- 魏以宣 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 顏志傑 Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Chiu Hung Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
190 participants
